Fluorescein- and EGFR-Antibody Conjugated Silica Nanoparticles for Enhancement of Real-time Tumor Border Definition Using Confocal Laser Endomicroscopy in Squamous Cell Carcinoma of the Head and Neck

Intraoperative definition of tumor free resection margins in head and neck cancer is challenging. In the current proof-of-principle study we evaluated a novel silica nanoparticle-based agent for its potential use as contrast enhancer. We synthesized silica nanoparticles with an average size of 45 nm...

Full description

Saved in:
Bibliographic Details
Published in:Nanomaterials (Basel, Switzerland) Switzerland), 2019-09, Vol.9 (10), p.1378
Main Authors: Watermann, Anna, Gieringer, Rita, Bauer, Anna-Maria, Kurch, Sven, Kiesslich, Ralf, Tremel, Wolfgang, Gosepath, Jan, Brieger, Juergen
Format: Article
Language:English
Subjects:
Antibodies
Biocompatibility
Cancer
Confocal microscopy
contrast agent
egfr
Endoscopy
Epidermal growth factor
Epidermal growth factor receptors
Ethanol
Fibroblasts
Fluorescein
Fluorescence
Growth factors
Head & neck cancer
Histology
Isocyanates
Larynx
Laser applications
Microscopy
Nanoparticles
Scanning microscopy
Silica
silica nanoparticles
Silicon dioxide
Squamous cell carcinoma
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Intraoperative definition of tumor free resection margins in head and neck cancer is challenging. In the current proof-of-principle study we evaluated a novel silica nanoparticle-based agent for its potential use as contrast enhancer. We synthesized silica nanoparticles with an average size of 45 nm and modified these particles with the fluorescence stain fluorescein isocyanate (FITC) for particle detection and with epidermal growth factor receptor (EGFR)-targeting antibodies for enhanced tumor specificity. The nanoparticles exhibited good biocompatibility and could be detected in vitro and in vivo by confocal laser scanning microscopy. Additionally, we show in an ex vivo setting that these modified nanoparticles specifically bind to tumor samples and could be detected using a handheld confocal fluorescence endomicroscope. From a clinical point of view, we believe that this method could be used for tumor border contrast enhancement and for better intraoperative definition of R-0 tumor resection.
ISSN:2079-4991
2079-4991
DOI:10.3390/nano9101378